Overview
Jeffrey Engelman is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Engelman is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma.
His clinical research consists of co-authoring 158 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of EGFR Positive Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Beth Israel Deaconess Medical Center - Hematology/Oncology
Daniel Costa is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Costa is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. His top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma.
Beth Israel Deaconess Medical Center - Hematology/Oncology
Deepa Rangachari is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Rangachari is rated as an Elite provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Thymectomy.
Beth Israel Deaconess Hospital - Plymouth Cancer Center
Irina Gurevich is an Internal Medicine provider in Plymouth, Massachusetts. Dr. Gurevich is rated as a Distinguished provider by MediFind in the treatment of EGFR Positive Lung Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerDr. Engelman isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerDr. Engelman isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Engelman isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Lung AdenocarcinomaDr. Engelman isAdvanced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Engelman isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Anal CancerDr. Engelman isExperienced. Learn about Anal Cancer.
- Breast CancerDr. Engelman isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Engelman isExperienced. Learn about Colorectal Cancer.
- Delayed GrowthDr. Engelman isExperienced. Learn about Delayed Growth.
- Neuroendocrine TumorDr. Engelman isExperienced. Learn about Neuroendocrine Tumor.
- Recurrent Respiratory PapillomatosisDr. Engelman isExperienced. Learn about Recurrent Respiratory Papillomatosis.